Inside Washington: User Fee Program Seeks to Spur Biotech Development

August 15, 2002

Jill Wechsler

Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor, jillwechsler7@gmail.com.

BioPharm International, BioPharm International-08-01-2002, Volume 15, Issue 8

PDUFA III boost manufacturer fees to cover postapproval surveillance and streamline the FDA review process

Related Content:

Guest Editorial: Quality Agreements with Contract Laboratories

Survival Guide to FDA Inspections: Part 1, To Prepare or Not to Prepare, There Is No Question

Virus Inactivation in the 1990s ? and into the 21st Century: Part 2, Red Blood Cells and Platelets